rs35446871

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The ENST00000506344.6(ANK2):​c.12390C>T​(p.Ile4130Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0309 in 1,614,054 control chromosomes in the GnomAD database, including 877 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.030 ( 86 hom., cov: 33)
Exomes 𝑓: 0.031 ( 791 hom. )

Consequence

ANK2
ENST00000506344.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.423

Publications

5 publications found
Variant links:
Genes affected
ANK2 (HGNC:493): (ankyrin 2) This gene encodes a member of the ankyrin family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton. Ankyrins play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. The protein encoded by this gene is required for targeting and stability of Na/Ca exchanger 1 in cardiomyocytes. Mutations in this gene cause long QT syndrome 4 and cardiac arrhythmia syndrome. Multiple transcript variants encoding different isoforms have been described. [provided by RefSeq, Dec 2011]
ANK2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, ClinGen
  • Brugada syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, ClinGen
  • catecholaminergic polymorphic ventricular tachycardia
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Genomics England PanelApp
  • heart conduction disease
    Inheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
  • neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • cardiac arrhythmia, ankyrin-B-related
    Inheritance: Unknown, AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.132).
BP6
Variant 4-113381478-C-T is Benign according to our data. Variant chr4-113381478-C-T is described in ClinVar as Benign. ClinVar VariationId is 136400.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.423 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0297 (4522/152294) while in subpopulation NFE AF = 0.033 (2243/68028). AF 95% confidence interval is 0.0318. There are 86 homozygotes in GnomAd4. There are 2178 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 4522 AD,Unknown gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000506344.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK2
NM_001148.6
MANE Select
c.*7C>T
3_prime_UTR
Exon 46 of 46NP_001139.3
ANK2
NM_001386174.1
c.12390C>Tp.Ile4130Ile
synonymous
Exon 51 of 51NP_001373103.1
ANK2
NM_001386175.1
c.12366C>Tp.Ile4122Ile
synonymous
Exon 50 of 50NP_001373104.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK2
ENST00000506344.6
TSL:1
c.12390C>Tp.Ile4130Ile
synonymous
Exon 51 of 51ENSP00000422888.2
ANK2
ENST00000514167.1
TSL:1
c.204C>Tp.Ile68Ile
synonymous
Exon 3 of 3ENSP00000422486.1
ANK2
ENST00000357077.9
TSL:1 MANE Select
c.*7C>T
3_prime_UTR
Exon 46 of 46ENSP00000349588.4

Frequencies

GnomAD3 genomes
AF:
0.0297
AC:
4519
AN:
152176
Hom.:
86
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0276
Gnomad AMI
AF:
0.0428
Gnomad AMR
AF:
0.0282
Gnomad ASJ
AF:
0.0568
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00600
Gnomad FIN
AF:
0.0330
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0330
Gnomad OTH
AF:
0.0382
GnomAD2 exomes
AF:
0.0280
AC:
7035
AN:
251000
AF XY:
0.0274
show subpopulations
Gnomad AFR exome
AF:
0.0261
Gnomad AMR exome
AF:
0.0216
Gnomad ASJ exome
AF:
0.0496
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0355
Gnomad NFE exome
AF:
0.0370
Gnomad OTH exome
AF:
0.0361
GnomAD4 exome
AF:
0.0311
AC:
45401
AN:
1461760
Hom.:
791
Cov.:
31
AF XY:
0.0306
AC XY:
22287
AN XY:
727186
show subpopulations
African (AFR)
AF:
0.0284
AC:
951
AN:
33480
American (AMR)
AF:
0.0226
AC:
1012
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.0507
AC:
1326
AN:
26132
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39690
South Asian (SAS)
AF:
0.00641
AC:
553
AN:
86254
European-Finnish (FIN)
AF:
0.0361
AC:
1926
AN:
53408
Middle Eastern (MID)
AF:
0.0291
AC:
168
AN:
5768
European-Non Finnish (NFE)
AF:
0.0338
AC:
37624
AN:
1111924
Other (OTH)
AF:
0.0305
AC:
1839
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
2460
4920
7379
9839
12299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1386
2772
4158
5544
6930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0297
AC:
4522
AN:
152294
Hom.:
86
Cov.:
33
AF XY:
0.0292
AC XY:
2178
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.0275
AC:
1144
AN:
41552
American (AMR)
AF:
0.0282
AC:
431
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0568
AC:
197
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00663
AC:
32
AN:
4826
European-Finnish (FIN)
AF:
0.0330
AC:
351
AN:
10622
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0330
AC:
2243
AN:
68028
Other (OTH)
AF:
0.0378
AC:
80
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
232
463
695
926
1158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0318
Hom.:
82
Bravo
AF:
0.0304
Asia WGS
AF:
0.00491
AC:
17
AN:
3478
EpiCase
AF:
0.0347
EpiControl
AF:
0.0357

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jul 10, 2011
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Cardiac arrhythmia, ankyrin-B-related Benign:3
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Oct 09, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
2.7
DANN
Benign
0.60
PhyloP100
-0.42
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35446871; hg19: chr4-114302634; API